09/02/2010
print this
article | 
email article to a friend
Canadian scientists have shown that taking the antidepressant paroxetine (brand name Seroxat) to relieve the side effects of the breast cancer drug Tamoxifen could result in a higher mortality when compared to those not taking paroxetine. Experts advise against any sudden decisions but recommend a review of the data to clarify the nature of the interaction.
Full article
Link:
http://www.bioscinews.co.uk/article.aspx?articleid=1916
BioSci Contact:
Jo Thurston
News Source:
Categories:
Endocrinology
|